LIGAND PHARMACEUTICALS INCORPORATED Employee-related Liabilities, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Employee-related Liabilities, Current of $4.63 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Employee-related Liabilities, Current $4.63M.
- 2026-03-31: Employee-related Liabilities, Current $3.55M.
- 2025-12-31: Employee-related Liabilities, Current $6.39M.
- 2025-09-30: Employee-related Liabilities, Current $3.70M.
| Period end | Employee-related Liabilities, Current | Employee-related Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.63M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $3.55M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $6.39M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $3.70M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.51M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $1.89M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $5.52M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $3.83M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $2.69M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $1.90M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $4.68M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $2.89M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.34M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.73M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $6.20M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $6.23M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $4.67M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $3.62M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $6.53M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $4.56M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $3.68M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $3.35M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $8.81M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $4.84M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $3.46M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $2.32M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.99M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $3.60M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $2.86M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.38M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.04M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $4.25M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.17M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.46M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $4.08M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $2.48M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.88M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.36M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.60M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $2.15M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.46M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $854.00K 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $1.71M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $1.49M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.40M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $795.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.71M 10-K · filed 2016-11-14 | $1.93M 10-K · filed 2014-12-01 |
| 2014-09-30 | $1.39M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $1.12M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $777.00K 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $1.93M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $1.73M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $1.13M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $915.00K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.81M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $1.16M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $682.00K 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $1.81M 10-K · filed 2013-03-14 |